Douglas K. Bratton, 10% Owner at Juno Therapeutics, Inc. (JUNO), bought 693,395 shares at $24.00 ($15.0M) on 2014-12-23, disclosed to the SEC on 2014-12-24.
Open-market purchase of $15.0M JUNO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 68,395 | $0 | 0.0% |
| 2 | $24.00 | 625,000 | $15.0M | 100.0% |
| Total | $21.63 avg | 693,395 | $15.0M | 100% |
| Filing → |
| DNLI | BUY | 2017-12-14 | $5.0M | — | Filing → |
| JUNO | SELL | 2015-07-02 | $2.2M | — | Filing → |
| JUNO | SELL | 2015-06-25 | $13.8M | — | Filing → |